1. Home
  2. FURY vs STTK Comparison

FURY vs STTK Comparison

Compare FURY & STTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fury Gold Mines Limited

FURY

Fury Gold Mines Limited

HOLD

Current Price

$0.57

Market Cap

115.8M

ML Signal

HOLD

Logo Shattuck Labs Inc.

STTK

Shattuck Labs Inc.

HOLD

Current Price

$6.02

Market Cap

792.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FURY
STTK
Founded
2008
2016
Country
Canada
United States
Employees
N/A
N/A
Industry
Precious Metals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
115.8M
792.9M
IPO Year
2011
2020

Fundamental Metrics

Financial Performance
Metric
FURY
STTK
Price
$0.57
$6.02
Analyst Decision
Strong Buy
Buy
Analyst Count
2
7
Target Price
$1.70
$10.00
AVG Volume (30 Days)
309.2K
756.8K
Earning Date
08-11-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
53.02
EPS
N/A
N/A
Revenue
N/A
$1,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.50
$1.70
52 Week High
$1.02
$8.33

Technical Indicators

Market Signals
Indicator
FURY
STTK
Relative Strength Index (RSI) 47.19 37.50
Support Level $0.57 $5.87
Resistance Level $0.64 $7.75
Average True Range (ATR) 0.02 0.30
MACD -0.01 -0.10
Stochastic Oscillator 35.83 21.33

Price Performance

Historical Comparison
FURY
STTK

About FURY Fury Gold Mines Limited

Fury Gold Mines Ltd is a Canadian-focused high-grade gold exploration company. The company's projects are strategically positioned in two prolific mining regions: the Eeyou Istchee James Bay Region of Quebec and the Kitikmeot Region in Nunavut. Fury Gold's project portfolio comprises the Committee Bay gold project in Nunavut, and the Eau Claire gold, Sakami gold, Elmer East gold and lithium, and Eleonore South gold projects in Quebec. Additionally, it also owns interests in the Kipawa rare earths project and has full ownership of the Zeus heavy rare earths project, both located in the Temiscamingue region of Quebec. The company operates in two reportable segments: Quebec and Nunavut.

About STTK Shattuck Labs Inc.

Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.

Share on Social Networks: